Literature DB >> 5454254

Pharmacodynamics of carbenicillin in hepatic and renal failure.

T A Hoffman, R Cestero, W E Bullock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5454254     DOI: 10.7326/0003-4819-73-2-173

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  21 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 4.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

5.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.

Authors:  E L Francke; G B Appel; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

7.  The disposition of carbenicillin in blood, other body fluids and tissues of buffalo calves (Bubalus bubalis).

Authors:  K S Brar; M S Bal
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

8.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

Authors:  R A Branch; J James; A E Read
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 9.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

10.  Determinants of serum antipyrine half-lives in patients with liver disease.

Authors:  R A Branch; C M Herbert; A E Read
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.